Additionally, FIHKO in cancer cells, particularly lung cancer, was shown to suppress tumor growth in an orthotopic lung tumor model by increasing angiomotin (Amot), a key component of the Hippo tumor suppressor pathway [28]. This evidence concerns the gene AMOT and lung carcinoma.